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The main aim of the investigation was to screen the silver and gold nanoparticle synthesized from the methanol 
concentrate of Punica granatum for its in vitro anticancer activity against MCF 2, PC3, A-549, HeLa, and HepG2 cell lines. 
Silver and gold nanoparticles were prepared from methanol concentrate of P. granatum and nanoparticle synthesized was 
analyzed by UV and TEM analysis. The impact of nanoparticles synthesized on MCF-2, PC3, A-549, HeLa, and HepG2 
disease cell lines was assessed by MTT colourimetric assay and the impact on cell cycle was assessed by flow cytometric 
method. After assessing the cytotoxicity effect, the impact of apoptosis was also analyzed. The TEM analysis showed the 
particle size of 25.56 and 22.02 nm for gold and silver nanoparticles respectively. The adequacy of silver nanoparticles 
synthesized from P. granatum against MCF-2, PC3, A-549, HeLa, and HepG2 cell line demonstrated that the hatching of 
malignancy cells decreased the suitability of PC-3 and A 549 cancer cells lines only with IC50 values as 108.7 and 
88.42 µg/mL respectively. Gold nanoparticles didn’t have any activity against all the cancer cell lines. Cell cycle analysis 
and apoptosis study showed that Silver nanoparticles are effective in controlling the cell cycle and blocking the apoptosis in 
all the cell lines used. P. granatum can be a very good anticancer drug for various cancer cell lines. All in all, P. granatum 
has a critical cell reinforcement movement and anticancer action. 
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Introduction 
Cancer being a deadly disease have a high rate of 
multiplication because of independent development 
signals, continued angiogenesis and can attack tissues 
and metastasize apart from that malignancy, cells 
show protection from apoptosis. Plants have a huge 
number of functioning constituents with remedial 
properties. Various traditional systems of treatment 
includes cancer preventing agent by mitigating, DNA 
fix, and acceptance of apoptosis, invulnerable 
initiation and hindrance of cell cycle movement
1,2
. 
Hindrance of cell cycle movement, relocation, and 
attack, together with activating apoptosis can be 
viewed as techniques for disease treatment. 
Punica granatum L. (Family Punicaceae/Lythraceae) 
commonly known as the pomegranate is a large 
deciduous shrub or a small tree up to 5-10 m in 
height, wild and cultivated throughout India up to an 
altitude of 2000 m in the hills
3
. In the traditional 
system of medicine, root and stem bark are used as 
astringent, cooling, anthelmintic, good for tapeworm, 
strengthening gums and diarrhoea; flowers are used 
for styptic to gums, ophthalmic pain, hematuria, 
intrinsic haemorrhage, haemorrhoids, diarrhoea, 
dysentery, ulcer, pharyngitis, and epistaxis; fruits are 
sweet, sour, astringent, cooling, tonic, aphrodisiac, 
laxative, diuretic, anaemia, hyperdipsia, dyspepsia, 
pharyngitis, ophthalmic pain, pectoral disease, 
splenic disorder, bronchitis, earache, and diarrhoea; 
fruit rind is used for dysentery, gastric disorder, 
bleeding piles, freckles, and gonorrhoea; seeds are 
used as astringent, stomachic, diuretic, cardiotonic, 




This plant has been reported to have antibacterial, 
antifungal, hypoglycemic, anti-oxidative, hypolipidemic, 
analgesic, immunomodulatory, anticonvulsant, 
anthelmintic, antifertility, antidiabetic, anti-
inflammatory, gastroprotective, uterine stimulant 
cytotoxic, carcinogenesis, angiogenesis, atherosclerosis, 
hypertension, carotid artery stenosis, myocardial 
perfusion, dental conditions, ultraviolet radiation, 












The aim of the present investigation was to green 
synthesis silver and gold nanoparticles and evaluate 
the in vitro anticancer movement against MCF-2, 
PC3, A-549, HeLa, and HepG2 cell lines, cell cycle 
impact, and apoptosis. 
 
Materials and Methods 
The P. granatum fruit was collected from the local 
market [Sarraki Market, J P Nagar] Bangalore, 
Karnataka (India), and verified by Department of 
Pharmacognosy, The Oxford College of Pharmacy.  
A Voucher specimen (TOCOP/02/2017-18) was 
deposited in The Oxford College of Pharmacy, 
Bangalore. The dried peel was air-dried. 
 
Preparation of extract 
The dried peel was air-dried and controlled with a 
mechanical processor, going through a strainer and 
put away in a sealed shut compartment. At that point, 
50 g of air-dried powder was constantly refluxed with 
50% methanol at 55 
o
C for 30 minutes on a water bath
17
. 
The solution was filtered and made up to 100 mL. 
 
Drugs and chemicals 
Silver nitrate and gold chloride were purchased 
from SD Fine Chemicals Ltd, Mumbai. Propidium 
iodide: Cat # P4864 from Sigma and RNase A:  
Cat # 109169 from Boehring Mannheim GmbH were 
purchased. All chemicals and reagents used in this 
study were at least of analytical grade. 
 
Synthesis of nanoparticles 
A set of 1, 2, and 3 mM aqueous solution of silver 
nitrate and gold chloride was prepared for synthesis 
for silver and gold nanoparticles
17
. Exactly 9 mL of 
each 1, 2, and 3 mM silver nitrate and gold chloride 
solution respectively was added to 0.1, 0.2, 0.3, 0.4, 
and 0.5 mL methanol extract of the dried peel fruit of 
P. granatum to obtain silver and gold nanoparticles. 
The different concentrations of silver nitrate, gold 
chloride, and extracts were used to standardize the 
optimum concentration of silver nitrate, gold chloride, 
and extract needed for the synthesis of silver and gold 
nanoparticles. We found 0.3 mL and 1 mM solutions 
were found to give the best yield. The nanoparticles 
were synthesized at room temperature and the 
formation of nanoparticles was confirmed by 
checking λmax using UV spectrophotometer. 
 
Lyophilisation procedure 
After the desired reaction period, the solution 
containing silver and gold nanoparticles were 
lyophilized. The reluctant samples were centrifuged 
10,000 rpm for 15 minutes. After 15 minutes, discard 
the supernatant and collect the pellet and freeze-dry. 
The lyophilized samples were kept in the freezer at  
4 °C for further analysis. 
 
Characterization of silver and Gold nanoparticles 
Ultra violet visible spectroscopy analyses were 
carried out by UV–visible spectrophotometer Shimadzu 
in the range of 200–800 nm, with a scanning speed of 
100 mm/min. The morphology examination of dried 
powder samples was analyzed by TEM analysis 
which gives information about the particle size. 
 
In vitro anticancer activity 
 
Preparation of test solutions 
The 32 mg/mL sample stock was prepared in sterile 
DMSO. For cytotoxicity studies, serial two-fold 
dilutions from 320 to 10 µg/mL were prepared which 
is then used for treatment. 
 
Cell lines and culture medium 
All the cell lines were procured from ATCC, stock 
cells were cultured in DMEM supplemented with 
10% inactivated Fetal Bovine Serum (FBS), penicillin 
(100 IU/mL), streptomycin (100 µg/mL) in a 
humidified atmosphere of 5% CO2 at 37 
o
C until 
confluent. The cell was dissociated with cell 
dissociating solution (0.2% trypsin, 0.02% EDTA, 
0.05% glucose in PBS). The viability of the cells is 
checked and centrifuged. Further, 50,000 cells/well 
were seeded in a 96 well plate and incubated for 24 h 
at 37 
o
C, 5% CO2 incubator. 
The cytotoxic assay screening was performed using 
MTT assay as per Mosmann
18
 method to test the 
cytotoxicity of P. granatum synthesized silver and 
gold nanoparticles against MCF 2, PC3, A-549, HeLa, 
and HepG2 cell lines. In brief, the monolayer cell 
culture was trypsinized and the cell count was 
adjusted to 1.0 x 10
5
 cells/mL using respective media 
containing 10% FBS. To each well of the 96 well 
microtiter plate, 100 µL of the diluted cell suspension 
(50,000 cells/well) was added. After 24 h, when a 
partial monolayer was formed, the supernatant was 
flicked off, the monolayer was washed once with 
medium and 100 µL of different test concentrations of 
test drugs were added on to the partial monolayer in 
microtiter plates. The plates were then incubated at  
37 
o
C for 24 h in a 5% CO2 atmosphere. After 
incubation, the test solutions in the wells were 
discarded and 100 µL of MTT (5 mg/10 mL of MTT 
in PBS) was added to each well. The plates were 




incubated for 4 h at 37 
o
C in a 5% CO2 atmosphere. 
The supernatant was removed and 100 µL of DMSO 
was added and the plates were gently shaken to 
solubilize the formed formazan. The absorbance was 
measured using a microplate reader at a wavelength 
of 590 nm. The percentage growth inhibition  
was calculated using the following formula and 
concentration of test drug needed to inhibit cell 
growth by 50% (IC50) values is generated from the 
dose-response curves for cell lines. 
 
% Inhibition = 100 – (OD of sample/OD of Control) x 100 
 
Cell cycle analysis  
Silver nanoparticle-induced changes in cell cycle 
were measured using the protocol
19
. In brief, MCF 2, 
PC3, A-549, HeLa, and HepG2 cell lines were 
exposed for 24 h at 10–50 µg/mL PGDSN. After the 
treatment, cells were fixed in chilled 70% ethanol for 
1 h. Then, cells were washed twice by centrifugation, 
and cells were stained with propidium iodide for  
60 minutes in dark. Stained cells were acquired by 
flow cytometer. 
In brief, 1 x10
6
 cells were seeded and cultured for 
24 hours in a 6-well plate containing 2 mL of serum-
free media. Cells were then treated with desired 
concentrations of given samples that were prepared in 
complete media and incubated for another 24 hours. 
Cells were then harvested and centrifuged at 2000 rpm 
for 5 minutes at room temperature and the supernatant 
was discarded carefully retaining the cell pellet. The 
cell pellet was washed by resuspending in 2 mL of 
1XPBS. The washing was repeated another time with 
the same conditions. The supernatant was discarded 
retaining the pellet. Cells were fixed by resuspending 
in 300 µL of Sheath fluid followed by the addition  
of 1 mL of chilled 70% EtOH drop by drop with 
continuous gentle shaking and another 1 mL of 
chilled 70% EtOH added at once. The cells were then 
stored at 4 °C overnight. Post fixing, the cells were 
centrifuged at 2000 rpm for 5 minutes. The cell pellet 
was washed twice with 2 mL of cold 1XPBS. The cell 
pellet was then resuspended in 500 µL of sheath fluid 
containing 0.05 mg/mL PI and 0.05 mg/mL RNase A 
and incubated for 15 minutes in dark. The percentage 
of cells in various stages of the cell cycle in 
compounds treated and un-treated populations were 
determined using FACS Caliber (BD Biosciences, 
San Jose, CA). 
 
Apoptosis assay 
Apoptosis/necrosis induced by silver nanoparticles 
in cancer cell lines was analyzed using Annexin-V 
and 7- AAD Kit (Beckman Coulter). The amount of 
apoptosis/necrosis in the treated MCF 2, PC3, A-549, 
HeLa, and HepG2 cell lines were analyzed by flow 
cytometry following the protocol
20
. 
In brief, the day before induction of apoptosis, 
plated 1 X 10
6
 MCF-2, PC3, A-549, HeLa, and HepG2 
cell lines per well for a 6-well plate using DMEM 
media with 10% FBS and 1% Pen Strep, incubated 
overnight at 37 ˚C at 5% CO2. The media was replaced 
with test solutions of different concentrations in the 
media containing 10% FBS. The treated cells were 
incubated for 24 hours at normal culture conditions. 
The cells were harvested and well contents were 
completely transferred to the sterile FACS tubes. The 
cell contents were centrifuged at 2000 rpm for 5 
minutes and the supernatant was discarded. Washed the 
cells twice with cold PBS following the centrifugation 
and then resuspended the cells in 1 mL 1X Binding 
Buffer at a concentration of ~1 x 10
6
 cells/mL. 
Transferred 500 μL of the cell suspension (~5 x 105 
cells) to a new FACS tube. Exactly 5 μL Annexin V 
and 10 μL PI were added to the tubes, cells were gently 
mixed and incubated for 20 minutes at room 
temperature in the dark. The cells were analyzed by 
flow cytometry as soon as possible (within 1 hour). 
 
Results and Discussion 
The UV spectroscopy of 50% methanol extract of 
dried peel (0.3 mL) of P. granatum at 55 
o
C are taken 
on Shimadazu UV spectrophotometer and graphs 
were taken from the software which is given in Fig. 1 
& 2. The peak at 400 to 450 nm and 570 to 590 nm 
formation means silver and gold nanoparticles are 
formed
21
. In TEM analysis, it was very clear that 
nanoparticles were synthesized and characterized as 
nanoparticles. The average particle size was 22.02 and 
25.56 nm for silver and gold nanoparticle respectively 
(Fig. 3 & 4). 
 
 
Fig. 1 — UV spectroscopy of silver nanoparticles synthesised 
from Punica granatum 
















Fig. 4 — TEM analysis of silver nanoparticles synthesised from 
Punica granatum 
 
It is seen that the administration of malignancy and 
irresistible sicknesses dependably require the quest 
for new medications. Albeit various medications  
are at present being used for malignant growth 
chemotherapy, they display cell poisonous quality, 
actuates genotoxic, cancer-causing, and teratogenic 
impacts in non-tumour cells. These reactions limit the 
utilization of chemotherapeutic specialists regardless 
of their high viability in treating target threatening 
cells. Along these lines, the quest for novel 
medications that are both viable and non-harmful 
bioactive plant items have been expanded. As of late, 
ethnobotanical and customary employments of normal 
mixes, particularly of plant inception got much 
consideration as they are very much tried for their 
viability and for most of it, accepted to be all right for 
human use. 
Traditionally, the in vitro determinations of toxic 
effects of unknown compounds have been performed 
by counting viable cells after staining with a vital dye. 
Alternative methods used are the measurement of 
radioisotope incorporation as a measure of DNA 
synthesis, counting by automated counters, and others 
that rely on dyes and cellular activity. The MTT system 
is a means of measuring the activity of living cells via 
mitochondrial dehydrogenases. The MTT method is 
simple, accurate, and yields reproducible results. The 
key component is (3-[4, 5- dimethylthiazol-2-yl]-2, 5-
diphenyl tetrazolium bromide), or MTT, which is a 
water-soluble tetrazolium salt yielding a yellowish 
solution when prepared in media or salt solutions 
lacking phenol red. Dissolved MTT is converted to an 
insoluble purple formazan by cleavage of the 
tetrazolium ring by mitochondrial dehydrogenase 
enzymes of viable cells. This water-insoluble formazan 
can be solubilized using DMSO, acidified isopropanol, 
or other solvents (Pure propanol or ethanol). 
The resulting purple solution is spectro-
photometrically measured. An increase or decrease in 
cell number results in a concomitant change in the 
amount of formazan formed, indicating the degree of 
effects caused by the test material
18
. 
The effect of silver nanoparticle synthesized from 
P. granatum against MCF-2, PC3, A-549, HeLa, and 
HepG2 cell line demonstrated that the hatching of 
malignancy cells decreased the suitability of PC-3 and 
A 549 cancer cells lines only with IC50 values as 
108.7 and 88.42 µg/mL respectively (Table 1, Fig. 5). 
It is also seen that gold nanoparticles didn’t have any 
activity against any MCF 2, PC3, A-549, HeLa, and 
HepG2 cell lines. Similar results were observed by 
other authors for HeLa and colon cancer on  








The cycle of increase in components (growth) and 
division followed by growth and division of these 
daughter cells, etc., is called the cell cycle. The two 
most obvious features of the cell cycle are the 
synthesis and duplication   of   nuclear   DNA   before 
division, and the process of cellular division itself -
mitosis. These two components of the cell cycle are 
usually indicated in shorthand as the “S phase” and 
“mitosis” or “M”. When the S phase and M phase of 
the cell cycle were originally described, it was 
observed that there was a temporal delay or gap 
between mitosis and the onset of DNA synthesis, and 
another gap between the completion of DNA 
synthesis and the onset of mitosis. These gaps were 
termed G1 and G2, respectively. One of the earliest 
applications of flow cytometry was the measurement 
of DNA content in cells. This analysis is based on the 
ability to stain the cellular DNA in a stoichiometric 
manner. A variety of dyes are available to serve this 
function, all of which have high binding affinities for 
DNA. The location to which these dyes bind on the 
DNA molecule varies with the type of dye used. The 
most common DNA binding dye in use today is the 
blue-excited dye Propidium Iodide (PI). PI is an 
intercalating dye which binds to DNA and double-
stranded RNA (and is thus almost always used in 
conjunction with RNase A to remove RNA). When 
diploid cells which have been stained with a dye that 
stoichiometrically binds to DNA are analyzed by flow 
cytometry, a “narrow” distribution of fluorescent 
intensities are obtained. The study suggests that the 
cells treated with the samples have shown a marked 
increase in % of cells in the S phase & G2M phase 
compared to control; as the checkpoints at these 
phases play a major role in DNA replication & cell 
division
20,24-26 
The result of silver nanoparticle PGDSN showed 
that G0/G1, S and G2M phase are 79.28, 7.44, 13.04; 
80.66, 8.12, 10.74; 73.14, 13.48, 12.74; 72.94, 12.42, 
14.14 and 81.78, 3.28, 14.7 for MCF 2, PC3, A 549, 
HEPG2, HeLa cells when compared to control as 
84.04, 3.10, 9.96; 73.18, 12.8, 13.88; 79.63, 4.93, 
10.19; 68.92, 10.99,18.16 and 82.14, 5.8, 11.56, 
respectively (Table 2, Fig 6 & 7). From the cell cycle 
analysis, it is clear that MCF2, A 549, and HEPG2 
cause an increase in S and G2M stage and HeLa 
causes an increase only in the G2M stage suggesting 
that PGDSN has a control on the cell replication and 
cell division. 
Apoptosis is a cell death process characterized by 
morphological and biochemical features occurring at 
different stages. Once triggered apoptosis proceeds 
with different kinetics depending on cell types and 
culminates with cell disruption and formation of 
Table 1 — Effect of cytotoxicity of different concentration of silver nanoparticles against cancers cell lines 
Nanoparticles cell lines 10µg/mL 20µg/mL 40µg/mL 80µg/mL 160µg/mL 320µg/mL 
PC3 PGDGN 6 11 18 26 32 40 
PC3 PGDSN 9 19 24 40 54 67 
A 549 PGDGN 8 14 22 27 35 43 
A 549 PGDSN 11 23 32 40 59 69 
MCF2 PGDGN 5 11 17 24 30 37 
MCF 2 PGDSN 3 9 20 25 29 35 
HEPG2 PGDGN 2 7 15 23 31 37 
HEPG2 PGDSN 4 12 20 26 30 39 
HeLa PGDGN 5 12 19 29 34 38 




Fig. 5 — Effect of cytotoxicity of different concentration of silver nanoparticles against cancers cell lines 
 




apoptotic bodies. A critical stage of apoptosis 
involves the acquisition of surface changes by dying 
cells that eventually results in the recognition and 
uptake of these cells by phagocytes. Different changes 
on the surface of apoptotic cells such as the 
expression of thrombospondin binding sites, loss of 
sialic acid residues, and exposure of a phospholipid 
like phosphatidylserine (PS) were described. 
Phospholipids are asymmetrically distributed 
between inner and outer leaflets of the plasma 
membrane with phosphatidylcholine and sphingomyelin 
exposed on the external leaflet of the lipid bilayer, 
and phosphatidylserine predominantly observed on 
the inner surface facing the cytosol. Exposure of  
PS on the external surface of the cell membrane  
has been reported for activated platelets and senescent 
erythrocytes. Recently, it was shown that cells 
undergoing apoptosis break up the phospholipid 
asymmetry of their plasma membrane and expose PS 
which is translocated to the outer layer of the 
membrane. This occurs in the early phases of 
apoptotic cell death during which the cell membrane 
remains intact. This PS exposure may represent a 
hallmark (early and widespread) in detecting dying 
cells. Annexin V, belonging to a recently discovered 
family of proteins, the annexin, with anticoagulant 
properties has proven to be a useful tool in detecting 
apoptotic cells since it preferentially binds to 
negatively charged phospholipids like PS in the 
presence of Ca
2+
 and shows minimal binding to 
phosphatidylcholine and sphingomyelin. 
Changes in PS asymmetry, which is analyzed by 
measuring Annexin V binding to the cell membrane, 
were detected before morphological changes 
associated with apoptosis have occurred and before 
membrane integrity has been lost. By conjugating 
FITC to Annexin V it is possible to identify and 
quantitate apoptotic cells on a single cell basis by 
flow cytometry. Staining cells simultaneously with 
FITC-Annexin V (green fluorescence) and the 
propidium iodide (red fluorescence) allows the 
discrimination of intact cells, early apoptotic and late 
apoptotic or necrotic cells
19
. A low concentration of 





The result of silver nanoparticle PGDSN showed 
that viable cell, early apoptotic cell, late apoptotic cell 
and necrotic cell are 65, 3.42, 21.76, 9.82; 80.32, 
2.24, 4.02, 13.42; 70.97, 4.84, 20.52, 3.67; 84.66, 
4.46, 6.68, 4.2 and 80.94, 3.02, 4.44, 11.62  for  MCF 
2, PC3, A 549, HEPG2, HeLa cells when compared to 
control as 95.42, 0.38, 0.40, 3.80; 92.42, 2.84, 3, 1.74, 
92.76, 0.19, 6.09, 0.96; 96.86, 1.28, 0.46, 1.4 and 96.6, 
0.14, 1.68, 1.58 respectively (Table 3, Fig. 8 & 9).  
Table 2 — Effect of silver nanoparticles against cancers cell lines 
on cell cycle 
  Sub G0 G0/G1 S G2M 
MCF 2 
control 
3.10 84.04 03.10 09.96 
MCF 2 
PGDSN 
0.52 79.28 07.44 13.04 
PC3  
control 
0.68 73.18 12.80 13.88 
PC3  
PGDSN 
0.76 80.66 08.12 10.74 
A 549 
control 
5.86 79.63 04.93 10.19 
A 549 
PGDSN 
1.32 73.14 13.48 12.74 
HEPG2 
control 
2.50 68.92 10.99 18.16 
HEPG2 
PGDSN 
0.84 72.94 12.42 14.14 
HeLa  
control 
0.82 82.14 05.80 11.56 
HeLa 
PGDSN 
0.38 81.78 03.28 14.70 
 
 
Fig. 6 — Effect of silver nanoparticles against cancers cell lines on cell cycle 





































Fig. 8 — Effect of silver nanoparticles against cancers cell lines on apoptosis 
 
Table 3 — Effect of silver nanoparticles against cancers cell lines on apoptosis 
  Viable cell Early apoptotic cell Late apoptotic Necrotic cell 
MCF 2 control 95.42 0.38 00.40 03.80 
MCF 2 PGDSN 65.00 3.42 21.76 09.82 
PC3 control 92.42 2.84 03.00 01.74 
PC3 PGDSN 80.32 2.24 04.02 13.42 
A 549 control 92.76 0.19 06.09 00.96 
A 549 PGDSN 70.97 4.84 20.52 03.67 
HEPG2 control 96.86 1.28 00.46 01.40 
HEPG2 PGDSN 84.66 4.46 06.68 04.20 
HeLa control 96.60 0.14 01.68 01.58 
HeLa PGDSN 80.94 3.02 04.44 11.62 
 
PGDSN caused decrease in viable cancer cells, 
increase in the number of late apoptotic and necrotic 
cells suggesting to possess apoptotic activity. 
Pomegranate extracts and their constituents are 
known to exert their activity by diverse mechanisms 
and are known to inhibit angiogenesis, proliferation, 
invasiveness, growth, and also to induce apoptosis
28
. 
These extracts (juice, seed oil, peel) individually and 
upon combinatorial treatment are reported to inhibit 
tumour growth. Interestingly, the combinatorial 
treatment was found to be more effective than 
treatment with a single extract
29
. Several in vivo 
studies have also elucidated the potential anticancer 
mechanism of the extracts
30,31
. 





























Fig. 9 — Flow cytometry analysis of apoptosis in A 549 cells 
 
As suggested from the results and previous studies on 
P. granatum it has been shown that silver nanoparticle 
has very good activity against cell lines. It is well known 
that a high amount of ROS generation could lead to 
apoptotic and necrotic cell death
32
. Excessive ROS 
generation has been linked with substantial DNA 
damage and apoptosis/necrosis
31
. The present results are 
well in accordance with the recent reports that have 
shown apoptosis cell death due to the exposure of 






The cytotoxicity study, inhibition of cell division, 
and an increase in the number of late apoptotic cell 
and necrotic cells suggest the role of silver 
nanoparticles in the prevention of proliferation of 
cancer cells. In the future, we have planned to target 
the silver nanoparticle at the site of the cancer cell 
itself. Thus, silver nanoparticles synthesized using the 
dried peel of P. granatum PGDSN is a promising 
agent for nano chemoprevention of various cancer 
cells used for the study. 
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